BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: von Arx C, Rea G, Napolitano M, Ottaiano A, Tatangelo F, Izzo F, Petrillo A, Clemente O, Di Sarno A, Botti G, Scala S, Tafuto S. Effect of Octreotide Long-Acting Release on Tregs and MDSC Cells in Neuroendocrine Tumour Patients: A Pivotal Prospective Study. Cancers (Basel) 2020;12:E2422. [PMID: 32859050 DOI: 10.3390/cancers12092422] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
Number Citing Articles
1 Seibert T, Loehrer PJ, O'Brien ARW. Thymoma With Triple Threat: Pure Red Cell Aplasia, Autoimmune Hemolytic Anemia, and T-Cell Large Granular Lymphocytic Leukemia. J Hematol 2022;11:223-32. [PMID: 36632575 DOI: 10.14740/jh1061] [Reference Citation Analysis]
2 Liu S, Li B, Li J, Sun S, Sun S, Wu Q. Neuroendocrine regulations in tissue-specific immunity: From mechanism to applications in tumor. Front Cell Dev Biol 2022;10:896147. [DOI: 10.3389/fcell.2022.896147] [Reference Citation Analysis]
3 Gao W, Wang X, Zhou Y, Wang X, Yu Y. Autophagy, ferroptosis, pyroptosis, and necroptosis in tumor immunotherapy. Signal Transduct Target Ther 2022;7:196. [PMID: 35725836 DOI: 10.1038/s41392-022-01046-3] [Cited by in Crossref: 8] [Cited by in F6Publishing: 14] [Article Influence: 8.0] [Reference Citation Analysis]
4 Wang S, Tan Q, Hou Y, Dou H. Emerging Roles of Myeloid-Derived Suppressor Cells in Diabetes. Front Pharmacol 2021;12:798320. [PMID: 34975496 DOI: 10.3389/fphar.2021.798320] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 4.0] [Reference Citation Analysis]